{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:46:05Z","timestamp":1778633165331,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ymgme.2024.108615","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:08:44Z","timestamp":1732900124000},"page":"108615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and biochemical abnormalities in a feline model of GM2 activator deficiency"],"prefix":"10.1016","volume":"144","author":[{"given":"Sidney J.","family":"Beecy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne S.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah M.K.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise B.","family":"Diffie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cuddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Kell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108615_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2760(98)00057-5","article-title":"The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein","volume":"1393","author":"Mahuran","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2024.108615_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4439(99)00074-5","article-title":"Biochemical consequences of mutations causing the GM2 gangliosidoses","volume":"1455","author":"Mahuran","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2024.108615_bb0015","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2839","article-title":"The GM2 gangliosidoses","author":"Gravel","year":"1995"},{"key":"10.1016\/j.ymgme.2024.108615_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijep.2017.08.001","article-title":"GM2 activator protein deficiency, mimic of Tay-Sachs disease","volume":"4","author":"Kochumon","year":"2017","journal-title":"Int. J. Epilepsy"},{"key":"10.1016\/j.ymgme.2024.108615_bb0025","first-page":"61","article-title":"GM2 activator deficiency caused by a homozygous exon 2 deletion in GM2A","volume":"38","author":"Hall","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ymgme.2024.108615_bb0030","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.94.15.8138","article-title":"Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment","volume":"94","author":"Liu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2024.108615_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00687809","article-title":"GM2 gangliosidosis in a Japanese spaniel","volume":"67","author":"Cummings","year":"1985","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/030098588902600203","article-title":"Canine GM2 gangliosidosis: morphological and biochemical analysis","volume":"26","author":"Singer","year":"1989","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00401-005-1040-6","article-title":"Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis","volume":"110","author":"Martin","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2024.108615_bb0055","doi-asserted-by":"crossref","first-page":"1242814","DOI":"10.3389\/fnmol.2023.1242814","article-title":"Characterization of a phenotypically severe animal model for human AB-variant GM2 gangliosidosis","volume":"16","author":"Deschenes","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymgme.2024.108615_bb0060","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.1987.tb05596.x","article-title":"Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel","volume":"48","author":"Ishikawa","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2024.108615_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneumeth.2014.01.035","article-title":"High resolution MRI anatomy of the cat brain at 3Tesla","volume":"227C","author":"Gray-Edwards","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ymgme.2024.108615_bb0070","first-page":"24","article-title":"Atypical juvenile presentation of G(M2) gangliosidosis AB in a patient compound-heterozygote for c.259G > T and c.164C > T mutations in the GM2A gene","volume":"11","author":"Martins","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2024.108615_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143397","article-title":"ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2024.108615_bb0080","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.febslet.2011.07.012","article-title":"Adipokine ganglioside GM2 activator protein stimulates insulin secretion","volume":"585","author":"Higashi","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2024.108615_bb0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj3590599","article-title":"Regulation of mammalian phospholipase D2: interaction with and stimulation by G(M2) activator","volume":"359","author":"Sarkar","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2024.108615_bb0090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/bbrc.1999.0621","article-title":"The GM2 activator protein, a novel inhibitor of platelet-activating factor","volume":"258","author":"Rigat","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2024.108615_bb0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bbrc.2009.05.116","article-title":"GM2 activator protein inhibits platelet activating factor signaling in rats","volume":"385","author":"Rigat","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2024.108615_bb0100","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1074\/jbc.273.22.13421","article-title":"Mild feline mucopolysaccharidosis type VI. Identification of an N-acetylgalactosamine-4-sulfatase mutation causing instability and increased specific activity","volume":"273","author":"Yogalingam","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108615_bb0105","doi-asserted-by":"crossref","first-page":"27259","DOI":"10.1074\/jbc.271.44.27259","article-title":"Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease","volume":"271","author":"Yogalingam","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2024.108615_bb0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2008.02.004","article-title":"Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis","volume":"94","author":"Martin","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2024.108615_bb0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/bj3280863","article-title":"Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats","volume":"328","author":"Berg","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2024.108615_bb0120","doi-asserted-by":"crossref","first-page":"231ra248","DOI":"10.1126\/scitranslmed.3007733","article-title":"Sustained normalization of neurological disease after intracranial gene therapy in a feline model","volume":"6","author":"McCurdy","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2024.108615_bb0125","first-page":"3","article-title":"The ten-twenty electrode system of the international federation","volume":"52","author":"Klem","year":"1999","journal-title":"Electroencephalogr. Clin. Neurophysiol. Suppl."},{"key":"10.1016\/j.ymgme.2024.108615_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0195-5616(88)50051-7","article-title":"Cerebrospinal fluid","volume":"18","author":"Cook","year":"1988","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.ymgme.2024.108615_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/1098612X241234556","article-title":"Life tables of annual life expectancy and risk factors for mortality in cats in the UK","volume":"26","author":"Teng","year":"2024","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.ymgme.2024.108615_bb0140","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1126\/science.174.4011.838","article-title":"Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency","volume":"174","author":"Baker","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2024.108615_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00692699","article-title":"Hereditary neurovisceral mannosidosis associated with alpha-mannosidase deficiency in a family of Persian cats","volume":"58","author":"Vandevelde","year":"1982","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0150","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1073\/pnas.91.8.2970","article-title":"Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease","volume":"91","author":"Walkley","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2024.108615_bb0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/adc.48.10.775","article-title":"Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients","volume":"48","author":"Brett","year":"1973","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2024.108615_bb0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease","volume":"29","author":"Gray-Edwards","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2024.108615_bb0165","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ymthe.2017.01.009","article-title":"Novel biomarkers of human GM1 Gangliosidosis reflect the clinical efficacy of gene therapy in a feline model","volume":"25","author":"Gray-Edwards","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2024.108615_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2008-1052386","article-title":"Neurophysiological investigations in GM1 and GM2 Gangliosidoses","volume":"15","author":"Pampiglione","year":"1984","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2024.108615_bb0175","series-title":"Magnetic Resonance of Myelination and Myelin Disorders","first-page":"96","author":"van der Knaap","year":"2005"},{"key":"10.1016\/j.ymgme.2024.108615_bb0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1566523218666180404162622","article-title":"Genetics and therapies for GM2 Gangliosidosis","volume":"18","author":"Cachon-Gonzalez","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymgme.2024.108615_bb0185","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/030098587901600602","article-title":"The gangliosidoses: comparative features and research applications","volume":"16","author":"Baker","year":"1979","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(78)90749-7","article-title":"Meganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: a Golgi study","volume":"143","author":"Purpura","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2024.108615_bb0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/266553a0","article-title":"Neurite induction in mature cortical neurones in feline GM1-ganglioside storage disease","volume":"266","author":"Purpura","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2024.108615_bb0200","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2460\/ajvr.1997.58.07.706","article-title":"Profile of electrodiagnostic abnormalities in cats with GM1 gangliosidosis","volume":"58","author":"Steiss","year":"1997","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymgme.2024.108615_bb0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2012.06.007","article-title":"Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy","volume":"107","author":"Rigat","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108615_bb0210","doi-asserted-by":"crossref","first-page":"276ra226","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2024.108615_bb0215","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ana.26756","article-title":"Life-limiting peripheral organ dysfunction in feline Sandhoff disease emerges after effective CNS gene therapy","volume":"94","author":"Johnson","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0220","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(95)92590-2","article-title":"Bone marrow transplantation for lysosomal diseases","volume":"345","author":"Walkley","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2024.108615_bb0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"Kakkis","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108615_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2015.10.006","article-title":"Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations","volume":"117","author":"Ruane","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108615_bb0235","first-page":"72","article-title":"The pathology of Tay-Sachs' disease, bull. N.Y","volume":"30","author":"Aronson","year":"1954","journal-title":"Acad. Med."},{"key":"10.1016\/j.ymgme.2024.108615_bb0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","article-title":"Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease","volume":"263","author":"Bradbury","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0245","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00598955","article-title":"Tay-Sachs disease: progression of changes on neuroimaging in four cases","volume":"34","author":"Fukumizu","year":"1992","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2024.108615_bb0250","first-page":"1219","article-title":"White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities","volume":"16","author":"Kroll","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0255","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00004728-199607000-00009","article-title":"MR findings in Tay-Sachs disease","volume":"20","author":"Mugikura","year":"1996","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ymgme.2024.108615_bb0260","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00247-005-1542-3","article-title":"Proton MR spectroscopy in three children with Tay-Sachs disease","volume":"35","author":"Aydin","year":"2005","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0265","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.gene.2013.06.030","article-title":"Late onset GM2 gangliosidosis mimicking spinal muscular atrophy","volume":"527","author":"Jamrozik","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2024.108615_bb0270","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1525-0016(03)00066-2","article-title":"Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease","volume":"7","author":"Matalon","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2024.108615_bb0275","doi-asserted-by":"crossref","first-page":"165ra163","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2024.108615_bb0280","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejpn.2009.11.006","article-title":"Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease","volume":"14","author":"Assadi","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0285","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/awaa161","article-title":"Global CNS correction in a large brain model of human alpha-mannosidosis by intravascular gene therapy","volume":"143","author":"Yoon","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2024.108615_bb0290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/nbm.1430","article-title":"Magnetic resonance spectroscopy of the occipital cortex and the cerebellar vermis distinguishes individual cats affected with alpha-mannosidosis from normal cats","volume":"23","author":"Magnitsky","year":"2010","journal-title":"NMR Biomed."},{"key":"10.1016\/j.ymgme.2024.108615_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101272","article-title":"Widespread correction of brain pathology in feline alpha-mannosidosis by dose escalation of intracisternal AAV vector injection","volume":"32","author":"Hunter","year":"2024","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.ymgme.2024.108615_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243006","article-title":"Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses","volume":"15","author":"Cavender","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2024.108615_bb0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpn.2007.05.008","article-title":"Proton MRS of a child with Sandhoff disease reveals elevated brain hexosamine","volume":"12","author":"Wilken","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0310","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/nbm.984","article-title":"MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff disease","volume":"18","author":"Lowe","year":"2005","journal-title":"NMR Biomed."},{"key":"10.1016\/j.ymgme.2024.108615_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914611","article-title":"Efficacy of adeno-associated virus serotype 9-mediated gene therapy for AB-variant GM2 Gangliosidosis","volume":"24","author":"Vyas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2024.108615_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119217","article-title":"Biochemical correction of GM2 ganglioside accumulation in AB-variant GM2 Gangliosidosis","volume":"24","author":"Deschenes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2024.108615_bb0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj2920571","article-title":"Over-expression of a functionally active human GM2-activator protein in Escherichia coli","volume":"292","author":"Klima","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2024.108615_bb0330","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0167-4838(97)00002-2","article-title":"Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay","volume":"1339","author":"Smiljanic-Georgijev","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2024.108615_bb0335","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jmb.2004.07.063","article-title":"Evidence for lipid packaging in the crystal structure of the GM2-activator complex with platelet activating factor","volume":"342","author":"Wright","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0340","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/mol.108.051003","article-title":"Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation","volume":"75","author":"Welch","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymgme.2024.108615_bb0345","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J. Lipid Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:10:44Z","timestamp":1738447844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1096719224004992"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108615","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biochemical abnormalities in a feline model of GM2 activator deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108615"}}